Incidence, disease phenotype at diagnosis, and early disease course in inflammatory bowel diseases in Western Hungary, 2002-2006.
about
Where are we on worms?The burden of inflammatory bowel disease in EuropeThe Changing Phenotype of Inflammatory Bowel DiseaseEpidemiology of inflammatory bowel diseases from west to east.Recent advances in clinical practice: a systematic review of isolated colonic Crohn's disease: the third IBD?Monotonous diets protect against acute colitis in mice: epidemiologic and therapeutic implications.Crohn's disease in Korea: past, present, and future.Incidence and natural history of ulcerative colitis in the Uppsala Region of Sweden 2005-2009 - results from the IBD cohort of the Uppsala Region (ICURE).Incidence and clinical course of Crohn's disease during the first year - results from the IBD Cohort of the Uppsala Region (ICURE) of Sweden 2005-2009.Inflammatory bowel disease in an underdeveloped region of Northeastern Brazil.Review article: the association of diet with onset and relapse in patients with inflammatory bowel disease.Biological therapy in inflammatory bowel diseases: access in Central and Eastern Europe.Prevalence and Risk Factors for Therapy Escalation in Ulcerative Colitis in the Swiss IBD Cohort Study.Microbiome-Epigenome Interactions and the Environmental Origins of Inflammatory Bowel DiseasesRisk factors for complications in patients with ulcerative colitisSimilar risk of depression and anxiety following surgery or hospitalization for Crohn's disease and ulcerative colitis.Evolution of disease phenotype in adult and pediatric onset Crohn's disease in a population-based cohortNormalization of plasma 25-hydroxy vitamin D is associated with reduced risk of surgery in Crohn's disease.Is early limited surgery associated with a more benign disease course in Crohn's disease?Trends and Factors Affecting Hospitalization Costs in Patients with Inflammatory Bowel Disease: A Two-Center Study over the Past Decade.Predicting Outcomes to Optimize Disease Management in Inflammatory Bowel Diseases.Inflammatory bowel disease course in Crohn's disease: is the natural history changing?Incidence and paris classification of pediatric inflammatory bowel disease.Anti-TNF trough levels and detection of antibodies to anti-TNF in inflammatory bowel disease: are they ready for everyday clinical use?A review of mortality and surgery in ulcerative colitis: milestones of the seriousness of the disease.Age-related differences in presentation and course of inflammatory bowel disease: an update on the population-based literature.The epidemiology of inflammatory bowel disease.The incidence of inflammatory bowel disease in Denmark 1980-2013: a nationwide cohort study.Never underestimate inflammatory bowel disease: High prevalence rates and confirmation of high incidence rates in Australia.Lack of utility of symptoms and signs at first presentation as predictors of inflammatory bowel disease in secondary care.Low colectomy rate five years after diagnosis of ulcerative colitis. Results from a prospective population-based cohort in Sweden (ICURE) diagnosed during 2005-2009.Association of extraintestinal manifestations and anaemia with disease outcomes in patients with inflammatory bowel disease.Influence of food and lifestyle on the risk of developing inflammatory bowel disease.Health Care Cost Analysis in a Population-based Inception Cohort of Inflammatory Bowel Disease Patients in the First Year of Diagnosis.Treatment Steps, Surgery, and Hospitalization Rates During the First Year of Follow-up in Patients with Inflammatory Bowel Diseases from the 2011 ECCO-Epicom Inception Cohort.Prospective population-based cohort of inflammatory bowel disease in the biologics era: Disease course and predictors of severity.Role of laparoscopic surgery in the treatment of ulcerative colitis; short- and mid-term results.Disease Outcome of Ulcerative Colitis in an Era of Changing Treatment Strategies: Results from the Dutch Population-Based IBDSL Cohort.Adeno-associated virus mediated delivery of Tregitope 167 ameliorates experimental colitis.Incidence and initial disease course of inflammatory bowel diseases in 2011 in Europe and Australia: results of the 2011 ECCO-EpiCom inception cohort.
P2860
Q22242718-2C4FCF11-CF05-4AE1-86C3-757215385CB0Q28285200-5E68E4C0-D75F-4FEF-873A-A6A022E7F5EBQ28354092-52BD42B7-0B8B-4EBD-9411-EB90CD44FF7BQ30238938-570159CE-2787-4145-A6C6-7E51BCBC9DD1Q30242073-9E5DE91C-B1A4-40DF-815F-9935A986D225Q33648217-6B093CA2-E80A-4C2A-AB42-891FC8EED31BQ34184560-045102E6-B5CD-40B1-87B0-AC3DEB9026DFQ34620405-380B540A-1F28-4A33-B22C-57646B995AEFQ34987163-EEC2D473-C918-4048-A5C7-8E758B9AB77FQ35012080-CA8F6E1C-00E1-4AED-8FDE-DBB769C52DEFQ35015511-57B3A128-32A4-412D-9244-0D6FB2B1252DQ35069447-8E90BB6D-0787-4E78-A52A-4DE01915E9ECQ35670802-9CAD8C38-7400-4946-9DF2-622F8F889A72Q35755739-BEF6BFA7-0D51-404D-9C34-E571C97E7BE1Q36719865-D2141A8F-CD1A-4513-A32B-58E46FA15969Q36769322-03486509-4DD0-4692-B8B9-E7C2735D76C5Q36770515-BD840E56-8F7D-4E57-BAAE-4FEF051AC3A6Q37039049-94C8F05D-95A7-4EA8-B31C-201BAFBD7A5CQ37334129-8711FAB0-4749-4A4A-9EE8-A885EBCD20CDQ37338282-7B25CA21-13D4-44E0-B4E3-B4D64E55F0EFQ37521805-6CCBE4A2-EE92-4244-B4A9-5DFF9C872EC6Q37660681-2779B88C-AABA-4125-A936-B0FFA7DC2C46Q37691029-E31B538F-82E5-4C1F-8FF3-1D7C0DAB50CCQ37965581-695624CF-2F9E-4CA3-9443-4DF6B565A96EQ38102563-BCC22228-432C-47B4-9381-3BFEF718AB44Q38222053-F966E96E-BA0F-4C32-A0C6-5BD8AE98AEECQ38357796-6731DCD2-A140-4F15-97F7-FEC0F1242DA3Q38946940-9C0C3998-6EEB-4731-871E-601B4FCD0A92Q38979895-6E99351A-1279-4A82-B175-606A430A37A4Q39013737-D637F228-1ABD-4C96-A7FC-7B70AA878EF2Q39645051-D661E074-EBEB-4EE8-B299-427AAB4C9B62Q39994805-6BC0E110-151E-4898-8C88-28D29F01E795Q40722752-0DFD669A-28D9-4378-AEDE-72A5562258F3Q40780802-1ED36B87-DF18-4D4F-A5E7-C5601CEAB2A1Q40856508-BD129A5D-4E9C-4497-9355-0696CE00206BQ41081620-165CE674-5AC7-4EFB-A41F-B54B3A7926B5Q41525245-166902B7-C179-4C5B-B06F-8737338B5BC3Q41573206-993C3055-F42E-4B06-85B9-2FF68D08502FQ42120838-A6856B38-0068-4DAF-8F08-779CEBD83762Q43525998-86D1AEDD-D5D8-4B42-A02D-B94D0DF87421
P2860
Incidence, disease phenotype at diagnosis, and early disease course in inflammatory bowel diseases in Western Hungary, 2002-2006.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年学术文章
@wuu
2011年学术文章
@zh
2011年学术文章
@zh-cn
2011年学术文章
@zh-hans
2011年学术文章
@zh-my
2011年学术文章
@zh-sg
2011年學術文章
@yue
2011年學術文章
@zh-hant
name
Incidence, disease phenotype a ...... in Western Hungary, 2002-2006.
@en
Incidence, disease phenotype a ...... in Western Hungary, 2002-2006.
@nl
type
label
Incidence, disease phenotype a ...... in Western Hungary, 2002-2006.
@en
Incidence, disease phenotype a ...... in Western Hungary, 2002-2006.
@nl
prefLabel
Incidence, disease phenotype a ...... in Western Hungary, 2002-2006.
@en
Incidence, disease phenotype a ...... in Western Hungary, 2002-2006.
@nl
P2093
P2860
P356
P1476
Incidence, disease phenotype a ...... in Western Hungary, 2002-2006.
@en
P2093
Csaba Molnar
Erzsebet Komaromi
Gabor Mester
Gyula David
Istvan Szipocs
Lajos S Kiss
Laszlo Lakatos
Mihaly Balogh
Peter Laszlo Lakatos
Tunde Pandur
P2860
P304
P356
10.1002/IBD.21607
P577
2011-01-06T00:00:00Z